scholarly article | Q13442814 |
P2093 | author name string | D Fuchs | |
B Widner | |||
T G Allen-Mersh | |||
A Huang | |||
D C Henderson | |||
C Glover | |||
P2860 | cites work | The hospital anxiety and depression scale | Q27860968 |
Modulation of cellular tryptophan metabolism in human fibroblasts by transforming growth factor-beta: selective inhibition of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA synthetase gene expression | Q28281800 | ||
Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse | Q28317802 | ||
Increased neopterin concentrations in patients with cancer: indicator of oxidative stress? | Q33724349 | ||
Cancer cachexia and depressive states: a neuro-endocrine-immunological disease? | Q34065106 | ||
Clinical and physiological consequences of rapid tryptophan depletion | Q34076826 | ||
Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist | Q35982281 | ||
Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells | Q36350042 | ||
Sickness behaviour, an animal equivalent to human quality of life, is improved in septic rats by G-CSF and antibiotic prophylaxis. | Q51356875 | ||
A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer. | Q51991229 | ||
Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum. | Q53510246 | ||
Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. | Q55054754 | ||
The Sickness Impact Profile: Development and Final Revision of a Health Status Measure | Q55063071 | ||
Immunoendocrine aspects of major depression | Q56767477 | ||
Brain mechanisms associated with depressive relapse and associated cognitive impairment following acute tryptophan depletion | Q57004092 | ||
Simultaneous measurement of serum tryptophan and kynurenine by HPLC | Q61906305 | ||
Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms | Q61906369 | ||
Plasma and CSF tryptophan in cancer anorexia | Q68913203 | ||
Immune reaction links disease progression in cancer patients with depression | Q74029838 | ||
Relation between depression and circulating immune products in patients with advanced colorectal cancer | Q77557667 | ||
Phase I study of percutaneous cryotherapy for colorectal liver metastasis | Q77711464 | ||
Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism | Q37349845 | ||
Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma | Q39024873 | ||
Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. | Q40386571 | ||
Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis. | Q40595922 | ||
Brain tryptophan and the neoplastic anorexia-cachexia syndrome | Q40608875 | ||
Transmembrane signaling by the interleukin-2 receptor: progress and conundrums | Q40790156 | ||
Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines by interferon-gamma. | Q41993576 | ||
Measurement of response to treatment in colorectal liver metastases | Q42209034 | ||
Mania induced by risperidone: dose related? | Q42544508 | ||
Fatigue in cancer | Q42772667 | ||
Paroxetine for the prevention of depression induced by high-dose interferon alfa | Q43556890 | ||
Contribution of diet, tumour volume and patient-related factors to weight loss in patients with colorectal liver metastases | Q47263654 | ||
Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases | Q47341724 | ||
Weight loss in patients with hematological neoplasias is associated with immune system stimulation | Q47400302 | ||
Fibrinogen synthesis is elevated in fasting cancer patients with an acute phase response | Q47752980 | ||
Cytokines and sickness behavior. | Q47966462 | ||
Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. | Q48139231 | ||
Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation | Q48255846 | ||
Plasma tryptophan and anorexia in human cancer | Q48409926 | ||
Relapse of depression after rapid depletion of tryptophan | Q48758651 | ||
Differential pharmacology of newer antidepressants. | Q48774817 | ||
Changes in brain amines associated with cancer anorexia | Q48849907 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported | Q15643954 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | colorectal cancer | Q188874 |
P304 | page(s) | 1691-1696 | |
P577 | publication date | 2002-06-01 | |
P1433 | published in | British Journal of Cancer | Q326309 |
P1476 | title | Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer | |
P478 | volume | 86 |
Q41582112 | (-)-Epigallocatechin gallate inhibits the expression of indoleamine 2,3-dioxygenase in human colorectal cancer cells |
Q34336333 | A novel serum metabolomics-based diagnostic approach for colorectal cancer |
Q64249063 | AMPKα2 knockout enhances tumour inflammation through exacerbated liver injury and energy deprivation-associated AMPKα1 activation |
Q33952214 | An observational cohort study of the kynurenine to tryptophan ratio in sepsis: association with impaired immune and microvascular function |
Q33870256 | BAR the door: cancer suppression by amphiphysin-like genes |
Q37874555 | Branched-chain amino acids as pharmacological nutrients in chronic liver disease |
Q45902054 | Cancer and intercellular cooperation. |
Q45959519 | Changes in serum tryptophan catabolism as an indicator of disease activity in adult T-cell leukemia/lymphoma. |
Q37024095 | Characterization of the microbiome of nipple aspirate fluid of breast cancer survivors |
Q47596077 | Clinical significance of tryptophan catabolism in Hodgkin lymphoma. |
Q99560869 | Clinical significance of tryptophan catabolism in follicular lymphoma |
Q50100354 | Conceptual Challenges in the Theoretical Foundations of Systems Biology. |
Q53727618 | Construction of a highly sensitive signal-on aptasensor based on gold nanoparticles/functionalized silica nanoparticles for selective detection of tryptophan. |
Q64964763 | Depression in terminally ill patients with cancer. |
Q42172050 | Diminished quality of life in patients with cancer correlates with tryptophan degradation |
Q38892525 | Early Immune Regulatory Changes in a Primary Controlled Human Plasmodium vivax Infection: CD1c+ Myeloid Dendritic Cell Maturation Arrest, Induction of the Kynurenine Pathway, and Regulatory T Cell Activation |
Q36535642 | Effect of branched-chain amino acid-enriched nutritional supplementation on interferon therapy in Japanese patients with chronic hepatitis C virus infection: a retrospective study |
Q54190983 | Expression of indoleamine 2,3-dioxygenase in leukemic cells indicates an unfavorable prognosis in acute myeloid leukemia patients with intermediate-risk cytogenetics. |
Q34277561 | Fatigue in patients with lung cancer is related with accelerated tryptophan breakdown |
Q34546698 | Formation of an N-formylkynurenine-derived fluorophore and its use for measuring indoleamine 2,3-dioxygenase 1 activity |
Q37445053 | Functional metagenomic profiling of intestinal microbiome in extreme ageing |
Q46951192 | HCV patients, psychopathology and tryptophan metabolism: analysis of the effects of pegylated interferon plus ribavirin treatment |
Q35221827 | Helicobacter pylori and serum kynurenine-tryptophan ratio in patients with colorectal cancer |
Q38047057 | Host indoleamine 2,3-dioxygenase: contribution to systemic acquired tumor tolerance. |
Q41945018 | IL-32 induces indoleamine 2,3-dioxygenase+CD1c+ dendritic cells and indoleamine 2,3-dioxygenase+CD163+ macrophages: Relevance to mycosis fungoides progression |
Q28180117 | Immune activation and degradation of tryptophan in coronary heart disease |
Q34936678 | Immuno-regulatory function of indoleamine 2,3 dioxygenase through modulation of innate immune responses |
Q37144901 | Immunosuppression routed via the kynurenine pathway: a biochemical and pathophysiologic approach. |
Q96953606 | Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies |
Q50223024 | Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism |
Q34603340 | Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms |
Q27025063 | Indoleamine 2,3 dioxygenase in intestinal disease |
Q63366136 | Indoleamine 2,3-dioxygenase 1 inhibition targets anti-PD1-resistant lung tumors by blocking myeloid-derived suppressor cells |
Q36809762 | Indoleamine 2,3-dioxygenase and tumor-induced tolerance |
Q60921434 | Indoleamine 2,3-dioxygenase expression and overall survival in patients diagnosed with breast cancer in Pakistan |
Q93045394 | Induction of tryptophan hydroxylase in the liver of s.c. tumor model of prostate cancer |
Q90176765 | Inflammation-Induced Tryptophan Breakdown is Related With Anemia, Fatigue, and Depression in Cancer |
Q38366476 | Inflammation-induced activation of the indoleamine 2,3-dioxygenase pathway: Relevance to cancer-related fatigue |
Q34616168 | Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds. |
Q48241209 | Kynurenine metabolism predicts cognitive function in patients following cardiac bypass and thoracic surgery |
Q34633683 | Kynurenine pathway metabolites in humans: disease and healthy States |
Q42498228 | Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients. |
Q37522460 | Manipulation of indoleamine 2,3 dioxygenase; a novel therapeutic target for treatment of diseases |
Q38859547 | Mechanisms of Inflammation-Associated Depression: Immune Influences on Tryptophan and Phenylalanine Metabolisms |
Q34618252 | Metabolic signatures of extreme longevity in northern Italian centenarians reveal a complex remodeling of lipids, amino acids, and gut microbiota metabolism |
Q53061043 | Metabolomics biomarkers of frailty in elderly breast cancer patients. |
Q41050161 | Neopterin as a biomarker of immune response in cancer patients |
Q61906267 | Non-invasive monitoring of kidney allograft rejection through IDO metabolism evaluation |
Q55346219 | Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors. |
Q36012223 | Picolinic acid in patients with chronic hepatitis C infection: a preliminary report |
Q44763703 | Possible role of cytokine-induced tryptophan degradation in anaemia of inflammation |
Q33818264 | Potential role of tryptophan and chloride in the inhibition of human myeloperoxidase |
Q36052673 | Pre-treatment effects of peripheral tumors on brain and behavior: neuroinflammatory mechanisms in humans and rodents. |
Q42216809 | Predictive and prognostic role of serum neopterin and tryptophan breakdown in prostate cancer |
Q38718929 | Prevention and treatment of cancers by immune modulating nutrients. |
Q37833087 | Prognostication of diffuse large B-cell lymphoma in the rituximab era. |
Q36747510 | Relationship between indoleamine 2,3-dioxygenase activity and lymphatic invasion propensity of colorectal carcinoma |
Q90706531 | Resistance Exercise Reduces Kynurenine Pathway Metabolites in Breast Cancer Patients Undergoing Radiotherapy |
Q47163480 | Revisiting the tryptophan-serotonin deficiency and the inflammatory hypotheses of major depression in a biopsychosocial approach |
Q30893057 | Selective paired ion contrast analysis: a novel algorithm for analyzing postprocessed LC-MS metabolomics data possessing high experimental noise |
Q39659168 | Serum concentrations of l-kynurenine predict clinical outcomes of patients with peripheral T-cell lymphoma, not otherwise specified |
Q45226436 | St. John's wort (Hypericum perforatum) counteracts cytokine-induced tryptophan catabolism in vitro |
Q36476449 | Systemic delivery of Salmonella typhimurium transformed with IDO shRNA enhances intratumoral vector colonization and suppresses tumor growth |
Q26775471 | Targeting the indoleamine 2,3-dioxygenase pathway in cancer |
Q93134464 | The Plasma [Kynurenine]/[Tryptophan] Ratio and Indoleamine 2,3-Dioxygenase: Time for Appraisal |
Q38974424 | The Potential Role of Cannabinoids in Modulating Serotonergic Signaling by Their Influence on Tryptophan Metabolism |
Q91975772 | The Role of Tryptophan-Kynurenine in Feather Pecking in Domestic Chicken Lines |
Q37959968 | The dendritic cell-regulatory T lymphocyte crosstalk contributes to tumor-induced tolerance |
Q38356502 | The potential of targeting indoleamine 2,3-dioxygenase for cancer treatment. |
Q41149149 | The status of immunosuppression in patients with stage IIIB or IV non-small-cell lung cancer correlates with the clinical characteristics and response to chemotherapy |
Q36143029 | Translational approaches to treatment-induced symptoms in cancer patients. |
Q33912950 | Tryptophan degradation in women with breast cancer: a pilot study |
Q91559758 | Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond |
Q34942871 | Utility of kynurenic acid for non-invasive detection of metastatic spread to lymph nodes in non-small cell lung cancer |
Q33600013 | Vitamin E status and quality of life in the elderly: influence of inflammatory processes |
Search more.